Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer

Cancer

Volumn 117, Issue 13, 2011, Pages 2961-2969

  Cooley, Mary E ^a,b   Emmons, Karen M ^a,c   Haddad, Robert ^a,d   Wang, Qian ^a   Posner, Marshall ^a,d   Bueno, Raphael ^d   Cohen, Tiffany Jen ^e   Johnson, Bruce E ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

cancer; evidence based tobacco treatment; patient preference; smoking cessation programs; smoking related malignancies

Indexed keywords

DRUGS USED IN THE TREATMENT OF ADDICTION;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CAUCASIAN; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEAD AND NECK CANCER; HEALTH CARE PERSONNEL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PARENTAL ATTITUDE; PATIENT CARE; PATIENT EDUCATION; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE;

ADULT; AGED; AGED, 80 AND OVER; COUNSELING; FEMALE; HEAD AND NECK NEOPLASMS; HEALTH PROMOTION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; QUESTIONNAIRES; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 79959605676     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25828     Document Type: Article

References (52)

1. Garces YI, Yang P, Parkinson J, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest. 2004; 126: 1733-1741. (Pubitemid 39643973)
2. Fox JL, Rosenzweig KE, Ostroff JS,. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer. 2004; 44: 287-293. (Pubitemid 38609436)
3. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997; 89: 1782-1788. (Pubitemid 27516232)
4. Baser S, Shannon VR, Eapen GA, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest. 2006; 130: 1784-1790. (Pubitemid 46033434)
5. Zevallos JP, Mallen MJ, Lam CY, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; 115: 4636-4644.
6. Hoffman KE, Horowitz NS, Russell AH,. Healing of vulvo-vaginal radionecrosis following revascularization. Gynecol Oncol. 2007; 106: 262-264. (Pubitemid 46898594)
7. Lu JF, Eppler SM, Wolf J, et al. Clinical pharmacokinetics of erlotinib in patients with solid tumors and exposure-safety relationship in patients with non-small cell lung cancer. Clin Pharmacol Ther. 2006; 80: 136-145. (Pubitemid 44160689)
8. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T,. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol. 2002; 28: 815-820. (Pubitemid 35402290)
9. Chen AM, Chen LM, Vaughan A, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome [published online ahead of print April 14, 2010]. Int J Radiat Oncol Biol Phys. 2010.
10. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
11. Backinger CL, Thornton-Bullock A, Miner C, et al. Building consumer demand for tobacco-cessation products and services: the National Tobacco Cessation Collaborative's consumer demand roundtable. Am J Prev Med. 2010; 38 (3 suppl): S307-S311.
12. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG,. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008; 34: 102-111.
13. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995; 75: 569-576.
14. Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004; 13: 346-358. (Pubitemid 38714196)
15. Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer. 2009; 66: 218-225.
16. Sarna LP, Brown JK, Lillington L, Rose M, Wewers ME, Brecht ML,. Tobacco interventions by oncology nurses in clinical practice: report from a national survey. Cancer. 2000; 89: 881-889. (Pubitemid 30658589)
17. Sarna L, Wewers ME, Brown JK, Lillington L, Brecht ML,. Barriers to tobacco cessation in clinical practice: report from a National Survey of Oncology Nurses. Nurs Outlook. 2001; 49: 166-172. (Pubitemid 33602054)
18. Garces YI, Hays JT,. Tobacco dependence: why should an oncologist care? J Clin Oncol. 2003; 21: 1884-1886. (Pubitemid 46638603)
19. Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2370-2377. (Pubitemid 46048292)
20. Greene FL, Page DL, Fleming ID, et al. eds. AJCC Staging Handbook. 6th ed. New York: Springer; 2002.
21. Ter-Minassian M, Zhai R, Asomaning K, et al. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis. 2008; 29: 2147-2152.
22. Zhai R, Liu G, Asomaning K, et al. Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis. 2008; 29: 2330-2334.
23. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE,. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003; 5: 13-25. (Pubitemid 36285465)
24. Cooley ME, Lundin R, Murray L,. Smoking cessation interventions in cancer care: opportunities for oncology nurses and nurse scientists. Annu Rev Nurs Res. 2009; 27: 243-272.
25. Kozlowski LT, Porter CQ, Orleans CT, Pope MA, Heatherton T., Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug Alcohol Depend. 1994; 34: 211-216.
26. Courvoisier DS, Etter JF,. Comparing the predictive validity of 5 cigarette dependence questionnaires. Drug Alcohol Depend. 2010; 107: 128-133.
27. Etter JF, Duc TV, Perneger TV,. Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction. 1999; 94: 269-281. (Pubitemid 29068967)
28. Borland R, Yong HH, O'Connor RJ, Hyland A, Thompson ME,. The reliability and predictive validity of the Heaviness of Smoking Index and its 2 components: findings from the International Tobacco Control Four Country study. Nicotine Tob Res. 2010; 12 (suppl): S45-S50.
29. Cooley ME, Sarna L, Brown JK, et al. Tobacco use in women with lung cancer. Ann Behav Med. 2007; 33: 242-250. (Pubitemid 47041343)
30. Evangelista LS, Sarna L, Brelcht ML, Padilla G, Chen J,. Health perceptions and risk behaviors of lung cancer survivors. Heart Lung. 2003; 32: 131-139. (Pubitemid 36529993)
31. Coups EJ, Dhingra KL, Heckman CJ, Manne SL,. Receipt of provider advice for smoking cessation and use of smoking cessation treatments among cancer survivors. J Gen Intern Med. 2009; 24 (suppl 2): S480-S486.
32. Karam-Hage M, Cinciripini PM,. Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists. Curr Oncol Rep. 2007; 9: 509-516. (Pubitemid 350081488)
33. Ebbert JO, Sood A, Hays JT, Dale LC, Hurt RD,. Treating tobacco dependence: review of the best and latest treatment options. J Thorac Oncol. 2007; 2: 249-256. (Pubitemid 47181332)
34. Cooley ME, Sipples RL, Murphy M, Sarna L,. Smoking cessation and lung cancer: oncology nurses can make a difference. Semin Oncol Nurs. 2008; 24: 16-26.
35. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993; 2: 261-270.
36. Radzikowska E, Roszkowski K, Glaz P,. Lung cancer in patients under 50 years old. Lung Cancer. 2001; 33: 203-211. (Pubitemid 32707901)
37. Gadgeel SM, Ramalingam S, Cummings G, et al. Lung cancer in patients <50 years of age: the experience of an academic multidisciplinary program. Chest. 1999; 115: 1232-1236. (Pubitemid 29230626)
38. Kerr S, Watson H, Tolson D, Lough M, Brown M,. Smoking after the age of 65 years: a qualitative exploration of older current and former smokers' views on smoking, stopping smoking, and smoking cessation resources and services. Health Soc Care Community. 2006; 14: 572-582. (Pubitemid 44630288)
39. Schnoll RA, Malstrom M, James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002; 46: 137-145. (Pubitemid 34175091)
40. Ruge J, Ilbricht S, Schumann A, Rumpf HJ, John U, Meyer C,. Intention to quit smoking: is the partner's smoking status associated with the smoker's intention to quit? Int J Behav Med. 2008; 15: 328-335.
41. Park EW, Tudiver F, Schultz JK, Campbell T,. Does enhancing partner support and interaction improve smoking cessation? A meta-analysis. Ann Fam Med. 2004; 2: 170-174. (Pubitemid 39329087)
42. Hughes JR,. Smokers' beliefs about the inability to stop smoking. Addict Behav. 2009; 34: 1005-1009.
43. Overcash JA,. Narrative research: a review of methodology and relevance to clinical practice. Crit Rev Oncol Hematol. 2003; 48: 179-184. (Pubitemid 37357299)
44. Kreuter MW, Geen MC, Cappella JN, et al. Narrative communication in cancer prevention and control: a framework to guide research and application. Ann Behav Med. 2007; 33: 221-235. (Pubitemid 47041341)
45. Hinyard LJ, Kreuter MW,. Using narrative communication as a tool for health behavior change: a conceptual, theoretical, and empirical overview. Health Educ Behav. 2007; 34: 777-792.
46. Hajek P, Stead LF, West R, Jarvis M, Lancaster T,. Relapse prevention interventions for smoking cessation [serial online]. Cochrane Database Syst Rev. 2009;(1):CD003999.
47. Orleans CT, Mabry PL, Abrams DB,. Increasing tobacco cessation in America: a consumer demand perspective. Am J Prev Med. 2010; 38 (3 suppl): S303-S306.
48. Hughes JR, Oliveto AH, Riggs R, et al. Concordance of different measures of nicotine dependence: 2 pilot studies. Addict Behav. 2004; 29: 1527-1539. (Pubitemid 39296522)
49. Gritz ER, Dresler C, Sarna L,. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2287-2293. (Pubitemid 41437826)
50. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002; 4: 149-159.
51. Toll BA, O'Malley SS, Katulak NA, et al. Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychol Addict Behav. 2007; 21: 534-544.
52. Fucito LM, Latimer AE, Salovey P, Toll BA,. Nicotine dependence as a moderator of message framing effects on smoking cessation outcomes. Ann Behav Med. 2010; 39: 311-317.